I. Klepalová et al. / Inorganica Chimica Acta 402 (2013) 109–115
115
perature overnight. After that, the volatiles were vacuum evapo-
References
rated and the residuum was extracted with hot hexane. The yellow
powder of the product was obtained after recrystallization from
the mixture ether/hexane at ꢁ20 °C. Yield: 835 mg (72%,
2.32 mmol). Anal. Calc. for C22H20MoO3: C, 46.68; H, 4.48. Found:
C, 46.56; H, 4.52%. 1H NMR (CDCl3, 400 MHz, 25 °C, d ppm): 5.76
(t, J(1H,1H) = 2.3 Hz, 2H, C5H4), 5.38 (t, J(1H,1H) = 2.3 Hz, 2H,
C5H4), 4.33 (s-br, 2H, CH2CH2OMe), 3.92 (s-br, 1H, C3H5), 3.60 (s-
br, 2H, CH2CH2OMe), 3.38 (s, 3H, CH2CH2OCH3), 2.82 (s-br, 2H,
[1] P.C.A. Bruijnincx, P.J. Sadler, Adv. Inorg. Chem. 61 (2009) 1.
[2] J. Reedijk, Eur. J. Inorg. Chem. (2009) 1303.
[3] C.G. Hartinger, P.J. Dyson, Chem. Soc. Rev. 38 (2009) 391.
[4] G. Gasser, I. Ott, N. Metzler-Nolte, J. Med. Chem. 54 (2011) 3.
[5] S.K. Hadjikakou, N. Hadjiliadis, Coord. Chem. Rev. 253 (2009) 235.
[6] P. Köpf-Maier, H. Köpf, Chem. Rev. 87 (1987) 1137.
[7] H. Köpf, P. Köpf-Maier, Angew. Chem. Int. Ed. Engl. 18 (1979) 477.
[8] P. Köpf-Maier, H. Köpf, Z. Naturforsch. B 34 (1979) 805.
[9] P. Köpf-Maier, M. Leitner, H. Köpf, J. Inorg. Nucl. Chem. 42 (1980) 1789.
[10] P. Köpf-Maier, T. Klapötke, J. Cancer Res, Clin. Oncol. 118 (1992) 216.
[11] P. Köpf-Maier, M. Leitner, R. Voigtlander, H. Köpf, Z. Naturforsch. C 34 (1979)
1174.
[12] P. Köpf-Maier, H. Köpf, Struct. Bonding (1988) 103.
[13] D. Wallis, J. Claffey, B. Gleeson, M. Hogan, H. Müller-Bunz, M. Tacke, J.
Organomet. Chem. 694 (2009) 828.
[14] O.R. Allen, R.J. Knox, P.C. McGowan, Dalton Trans. (2008) 5293.
[15] K. Mross, P. Robben-Bathe, L. Edler, J. Baumgart, W.E. Berdel, H. Fiebig, C.
Unger, Onkologie 23 (2000) 576.
[16] N. Kröger, U.R. Kleeberg, K. Mross, L. Edler, G. Sass, D.K. Hossfeld, Onkologie 23
(2000) 60.
[17] G. Lümmen, H. Sperling, H. Luboldt, T. Otto, H. Rübben, Cancer Chemother.
Pharmacol. 42 (1998) 415.
C3H5), 1.03 (s-br, 2H, C3H5). FTIR (ATR, cmꢁ1): 3101 m [
Cp)], 3088 m [ (CH, Cp)], 1941vs [ a(CO)], 1858vs [ s(CO)], 1704s
(CO, COOR)].
m(CH,
m
m
m
[
m
4.18. Synthesis of Cp2VBr2
The steps of synthesis followed the procedure for compound 9.
Reagents: Cp2VCl2 (49 mg; 0.19 mmol), BBr3 (33 mg; 0.13 mmol).
Yield: 41 mg (0.12 mmol, 64%). Anal. Calc. for C10H10Br2V: C,
35.23; H, 2.96. Found: C, 35.27; H, 2.94. EPR(CH2Cl2): giso = 2.024,
|Aiso| = 67.2 G. Single crystals suitable for X-ray analysis were ob-
tained by diffusion diethyl ether vapors into CH2Cl2 solution of
Cp2VBr2.
[18] P.W. Causey, M.C. Baird, S.P.C. Cole, Organometallics 23 (2004) 4486.
[19] O.R. Allen, L. Croll, A.L. Gott, R.J. Knox, P.C. McGowan, Organometallics 23
(2004) 288.
[20] O.R. Allen, A.L. Gott, J.A. Hartley, J.M. Hartley, R.J. Knox, P.C. McGowan, Dalton
Trans. (2007) 5082.
[21] J.R. Boyles, M.C. Baird, B.G. Campling, N. Jain, J. Inorg. Biochem. 84 (2001) 159.
[22] K. Strohfeldt, M. Tacke, Chem. Soc. Rev. 37 (2008) 1174.
4.19. Synthesis of Cp2NbBr2
ˇ
ˇ
ˇ
[23] J. Honzícek, J. Vinklárek, I. Klepalová, Z. Padelková, I. Císarová, P. Šiman, M.
ˇ
ˇ
Rezácová, Inorg. Chim. Acta 373 (2011) 1.
The steps of synthesis followed the procedure for compound 9.
Reagents: Cp2NbCl2 (43 mg; 0.15 mmol), BBr3 (25 mg; 0.10 mmol).
Yield: 42 mg (0.11 mmol, 72%). Anal. Calc. for C10H10Br2Nb: C,
31.37; H, 2.63. Found: C, 31.32; H, 2.58%. EPR(CH2Cl2): giso = 2.013,
|Aiso| = 106.4 G.
[24] B. Gleeson, J. Claffey, A. Deally, M. Hogan, L.M.M. Méndez, H. Müller-Bunz, S.
Patil, D. Wallis, M. Tacke, Eur. J. Inorg. Chem. (2009) 2804.
[25] B. Gleeson, J. Claffey, M. Hogan, H. Müller-Bunz, D. Wallis, M. Tacke, J.
Organomet. Chem. 694 (2009) 1369.
[26] B. Gleeson, A. Deally, H. Müller-Bunz, S. Patil, M. Tacke, Aust. J. Chem. 63
(2010) 1514.
[27] B. Gleeson, M. Hogan, H. Müller-Bunz, M. Tacke, Trans. Met. Chem. 35 (2010)
973.
[28] B. Gleeson, J. Claffey, A. Deally, M. Hogan, L.M.M. Méndez, H. Müller-Bunz, S.
4.20. Crystallography
Patil, M. Tacke, Inorg. Chim. Acta 363 (2010) 1831.
ˇ
The X-ray data for crystals of Cp2VBr2, 7, 9ꢀCH2Cl2, 13, 15 and 16
ˇ
´
[29] M. Rezácová, A. Tichy, J. Vávrová, D. Vokurková, E. Lukášová, Leukemia Res. 32
(2008) 1259.
were obtained at 150 K using Oxford Cryostream low-temperature
ˇ
ˇ
ˇ
ˇ
[30] J. Honzícek, J. Vinklárek, Z. Padelková, L. Šebestová, K. Foltánová, M. Rezácová,
J. Organomet. Chem. 716 (2012) 258.
device on a Nonius KappaCCD diffractometer with Mo K
(k = 0.71073 Å), a graphite monochromator, and the / and
a
radiation
scan
v
ˇ
ˇ
ˇ
ˇ
[31] J. Vinklárek, H. Palácková, J. Honzícek, J. Holubová, M. Holcapek, I. Císarová,
Inorg. Chem. 45 (2006) 2156.
mode. Data reductions were performed with DENZO-SMN [49].
The absorption was corrected by integration methods [50]. Struc-
tures were solved by direct methods (Sir92) [51] and refined by full
ˇ
[32] J. Honzícek, A. Mukhopadhyay, T.S. Silva, M.J. Romão, C.C. Romão,
Organometallics 28 (2009) 2871.
[33] B. Dorer, M.H. Prosenc, U. Rief, H.H. Brintzinger, Collect. Czech. Chem.
Commun. 62 (1997) 265.
matrix least-square based on F2
(SHELXL97) [52]. Crystallographic
[34] B. Dorer, J. Diebold, O. Weyand, H.H. Brintzinger, J. Organomet. Chem. 427
data are summarized in the Table 5.
(1992) 245.
Hydrogen atoms were mostly localized on a difference Fourier
map, however to ensure uniformity of treatment of the crystal,
all hydrogen atoms were recalculated into idealized positions (rid-
ing model) and assigned temperature factors Hiso(H) = 1.2 Ueq (pi-
vot atom) or of 1.5 Ueq for the methyl moiety with C–H = 0.96,
0.97, and 0.93 Å for methyl, methylene and hydrogen atoms in
Cp ring, respectively.
ˇ
ˇ
ˇ
[35] J. Honzícek, H. Palácková, J. Vinklárek, I. Císarová, J. Organomet. Chem. 691
(2006) 202.
[36] P.B. Hitchcock, M.F. Lappert, R.C. Milne, J. Chem. Soc., Dalton Trans. (1981)
180.
[37] W.P. Hart, D.W. Macomber, M.D. Rausch, J. Am. Chem. Soc. 102 (1980) 1196.
[38] W.P. Hart, D. Shihua, M.D. Rausch, J. Organomet. Chem. 282 (1985) 111.
[39] L. Busetto, C. Cassani, V. Zanotti, V.G. Albano, P. Sabatino, Organometallics 20
(2001) 282.
[40] P. Tundo, F. Arico, A.E. Rosamilia, M. Rigo, A. Maranzana, G. Tonachini, Pure
Appl. Chem. 81 (2009) 1971.
[41] Q.Y. Wang, J. Yao, Y. Wang, G.Y. Wang, Ind. Catal. 13 (2005) 27.
[42] J. Petersen, F. Dahl, J. Am. Chem. Soc. 97 (1975) 6422.
Acknowledgement
ˇ
[43] J. Honzícek, J. Vinklárek, P. Nachtigall, Chem. Phys. 305 (2004) 291.
This work was supported by Ministry of Education of the Czech
Republic (Project No. SG320001).
ˇ
ˇ
[44] J. Honzícek, J. Vinklárek, I. Císarová, M. Erben, Inorg. Chim. Acta 362 (2009)
83.
[45] K. Prout, T.S. Cameron, R.A. Forder, S.R. Critchley, B. Denton, G.V. Rees, Acta
Crystallog., Sect. B 30 (1974) 2290.
[46] W.L.F. Armarego, D.D. Perrin, Purification of Laboratory Chemicals,
Butterworth-Heinemann, Oxford, 1996.
Appendix A. Supplementary material
[47] G. Wilkinson, J.M. Birmingham, J. Am. Chem. Soc. 76 (1954) 4281.
[48] L.E. Manzer, Inorg. Chem. 16 (1977) 525.
[49] Z. Otwinowski, W. Minor, Methods Enzymol. 276 (1997) 307.
[50] P. Coppens, in: F.R. Ahmed, S.R. Hall, C.P. Huber (Eds.), Crystallographic
Computing, Munksgaard, Copenhagen, 1970, pp. 255.
[51] A. Altomare, G. Cascarano, C. Giacovazzo, A. Guagliardi, M.C. Burla, G. Polidori,
M. Camalli, J. Appl. Cryst. 27 (1994) 435.
[52] G.M. Sheldrick, SHELXL97, University of Göttingen, Germany, 1997.
CCDC 907623–907628 contain the supplementary crystallo-
graphic data for this paper. These data can be obtained free of
charge from The Cambridge Crystallographic Data Centre via
associated with this article can be found, in the online version, at